Abstract
AKR/J mice immunized with several syngeneic leukemia cells contained antibodies in their sera which reacted with certain AKR leukemia cell lines, depending on their H-2 expression, and precipitated H-2K antigens from lysates of leukemia cells. Precipitation of H-2K was not due to virus-specific antibodies: it could not be blocked by prior absorption with H-2-negative leukemias, but was blocked by certain allogeneic lymphocytes. Tumor-specific H-2K antibodies did not react with H-2K from normal AKR lymphocytes either on the cell surface or after detergent solubilization; however, they did react with H-2K from mitogen-activated AKR and BALB.K lymphoblasts. Since both these latter cells were also lysed by AKR-Gross/MuLV-specific and H-2Kk-restricted cytotoxic T lymphocytes, we consider the possibility that antibodies detecting conformational alterations induced in H-2Kk molecules by viral association may be present in syngeneic AKR antileukemia sera.
Similar content being viewed by others
Abbreviations
- GCSA:
-
Gross-virus-induced cell-surface antigen
- MCF:
-
mink cell focus-forming virus
- MuLV:
-
murine leukemia virus
- Th:
-
T helper
References
Benaceraff, B. and Germain, R. N.: The immune response genes of the major histocompatibility complex. Immunol. Rev. 38: 70–119, 1978
Bevan, M. F.: Killer cells reactive to altered-self antigens can also be alloreactive. Proc. Natl. Acad. Sci. U.S.A. 74: 2094–2098, 1977
Blank, K. J. and Lilly, F.: Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity. Nature 269: 808–809, 1977
Černý-Provazník, R., van Mourik, P., Limpens, J., Leupers, T., and Ivanyi, P.: Anti-MHC immunity detected prior to intentional alloimmunization. III. Natural autoreactive H-2-specific antibodies. Immunogenetics 21: 491–504, 1985
Cook, R. G., Jenkins, R. N., Flaherty, L., and Rich, P. R.: The Qa-I alloantigens. II. Evidence for the expression of two Qa-I molecules by the Qa-Id genotype and for cross-reactivity between Qa-I and H-2Kf. J. Immunol. 130: 1293–1299, 1983
Doherty, P. C., Blanden, R. V., and Zinkernagel, R. M.: Specificity of virus-immune effector T cells for H-2K and H-2D compatible interactions; implications for H-antigen diversity. Transplant. Rev. 29: 89–124, 1976
Festenstein, M. and Schmidt, W.: Variations in MHC antigenic profiles on tumor cells and its biological effects. Immunol. Rev. 60: 85–127, 1981
Figueroa, F., Zaleska-Rutcznsky, Z., Kusnierczyk, P., and Klein, J.: Crossreactivity between Qa-1 region and H-2K antigens. Transplantation 35: 391–393, 1983
Finberg, R., Burakoff, S. J., Cantor, H., and Benacerraf, B.: Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells. Proc. Natl. Acad. Sci. U.S.A. 75: 5145–5149, 1978
Froscher, B. G. and Klinman, N. R.: Immunization with SV40-transformed cells yields mainly MHC-restricted monoclonal antibodies. J. Exp. Med. 164: 196–210, 1986
Haas, W., Mathur-Rochat, J., Kisielow, P., and von Boehmer, H.: Cytolytic T cell hybridomas. III. The antigen specificity and the restriction specificity of cytolytic T cells do not phenotypically mix. Eur. J. Immunol. 15: 963–965, 1985
Hale, A. H.: The spatial relationship of the viral and H-2 antigens recognized by anti-viral CTLs. Immunogenetics 10: 469–479, 1980
Hauptfeld, V., Nahm, M., Hauptfeld, M., and Schreffler, D. C.: Monoclonal antibodies to mouse MHC antigens. I. Serologic characterization of ten anti-H-2 and anti-Ia reagents. Immunogenetics 19: 169–173, 1984
Hubbard, A. L. and Colin, Z. A. J.: The enzymatic iodination of the red cell membrane. J. Cell Biol. 55: 390–405, 1972
Ivanyi, P., Melief, C. J. M., van Mourik, P., Vlug, A., and de Greeve, P.: Lymphocytotoxic antibodies produced by H-2 allo-immunization distinguish MuLV-positive and -negative sub-strains of the same H-2 haplotype. Nature 282: 843–845, 1979
Ivanyi, P., van Mourik, P., Breuning, M., and Melief, C. J. M.: Anti-H-2 antibodies induced by syngeneic immunization. Immunogenetics 10: 319–332, 1980
Ivanyi, P., van Mourik, P., Breuning, M., Kruisbeek, A. M., and Kröse, C. J. M.: Natural H-2-specific antibodies in sera of aged mice. Immunogenetics 15: 95–112, 1982
Klein, J., Juretic, A., Baxevanis, C. N., and Nagy, Z. A.: The traditional and a new version of the mouse H-2 complex. Nature 291: 455–460, 1981
Klöting, I. and Stark, O.: Occurrence of antibodies against gene products of the major histocompatibility complex in normal sera of diabetes-prone BB rats. Folia Biol. (Praha) 31: 34–37, 1985
Lemke, M., Hämmerling, G. J., and Hämmerling, U.: Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice. Immunol. Rev. 47: 175–206, 1979
Lemonnier, F. A., Le Bouteiller, P. P., Malissen, B., Golstein, P., Malissen, M., Mishal, Z., Caillol, D. H., Jordan, B. R., and Kourilsky, F. M.: Transformation of murine LMTK-cells with puri fied HLA class I genes. I. Modification of conformation of murine β 2 microglobulin upon its association with HLA heavy chains. J. Immunol. 130: 1432–1438, 1983
Levy, R. B., Dower, S. K., and Shearer, G. M.: Trinitrophenyl modification of H-2k and H-2b spleen cells results in enhanced serological detection of Kk-like determinants. J. Exp. Med. 159: 1464–1472, 1984
Linsk, R., Vogel, J., Stauss, H., Forman, J., and Goodenow, R. S.: Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma. J. Exp. Med. 164: 794–813, 1986
Mann, D. L., Poperic, M., Sarin, P., Murray, C., Reitz, M. S., Strong, D. M., Haynes, B. F., Gallo, R. C., and Blattner, W. A.: Cell lines producing human T-cell lymphoma virus show altered HLA expression. Nature 305: 58–60, 1983
Matzinger, P.: A one-receptor view of T-cell behaviour. Nature 292: 497–501, 1981
Ozato, K. and Sachs, D. H.: Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J. Immunol. 126: 317–321, 1981
Ozato, K., Mayer, N., and Sachs, D. H.: Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124: 533–540, 1980
Ozato, K., Mayer, N. M., and Sachs, D. H.: Monoclonal antibodies to mouse major histocompatibility antigens. Transplantation 34: 113–120, 1982
Parmiani, G., Carbone, G., Invernizzi, G., Pierotti, M. A., Sensi, M. L., Rogers, M. J., and Appella, E.: Alien histocompatibility antigens on tumor cells. Immunogenetics 9: 1–24, 1979
Pinter, A., Honnen, W. J., Tung, J. S., O'Donnell, P. V., and Hämmerling, U.: Structural domains of endogenous murine leukemia virus gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116: 499–516, 1982
Plata, F. and Lilly, F.: Viral specificity of H-2 restricted T killer cells directed against syngeneic tumors, induced by Gross, Friend, or Rauscher leukemia virus. J. Exp. Med. 150: 1174–1186, 1979
Risser, R. and Grunwald, D. J.: Production of anti-self H-2 antibodies by hybrid mice immune to a viral tumor. Nature 289: 503–568, 1981
Schäfer, A. and Schmidt, W.: Resistance to cellular immune response in AKR leukemias. Eur. J. Immunol. 16: 753–759, 1986
Schmidt, W. and Festenstein, H.: Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia. Immunogenetics 16: 257–264, 1982
Schmidt, W., Leben, L., Atfield, G., and Festenstein, H.: Variation of expression of histocompatibility antigens on tumor cells: Absence of H-2K gene products from a Gross-virus-induced leukemia in BALB.K. Immunogenetics 14: 323–339, 1981
Schmidt, W., Henseling, U., Bevec, D., Alonzo, A. D. R., and Festenstein, H.: Control of synthesis and expression of H-2 heavy chain and beta-2 microglobulin in AKR leukemias. Immunogenetics 22: 483–494, 1985
Strand, M., Lilly, F., and August, J. T.: Host control of endogenous murine leukemia virus gene expression: Concentration of viral proteins in high and low leukemia mouse strains. Proc. Natl. Acad. Sci. U.S.A. 71: 3682–3686, 1974
Tongio, M. M., Falkenrodt, A., Mitsuishi, Y., Urlacher, A., Bergerat, J. P., North, M. L., and Mayer, S.: Natural HLA antibodies. Tissue Antigens 26: 271–285, 1985
Van Leeuwen, A., Goulmy, E., and Van Rood, J. J.: Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors. J. Exp. Med. 150: 1075–1083, 1979
Wylie, D., Sherman, L. A., and Klinman, M. R.: The participation of the major histocompatibility complex in the recognition of viral antigens expression of infected cells. J. Exp. Med. 155: 403–414, 1982
Zinkernagel, R. M., Callahan, G. N., Althage, A., Cooper, S., Klein, P. A., and Klein, J.: On the thymus in the differentiation of H-2 self-recognition by T cells: Evidence for dual recognition. J. Exp. Med. 147: 882–896, 1978
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, W. H-2-specific antibodies induced by injection of syngeneic leukemia cells. Immunogenetics 25, 215–221 (1987). https://doi.org/10.1007/BF00404690
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00404690